Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 2/2011

Open Access 01-04-2011 | Mitochondrial Medicine

Biochemical diagnosis of mitochondrial disorders

Author: Richard J. T. Rodenburg

Published in: Journal of Inherited Metabolic Disease | Issue 2/2011

Login to get access

Abstract

Establishing a diagnosis in patients with a suspected mitochondrial disorder is often a challenge. Both knowledge of the clinical spectrum of mitochondrial disorders and the number of identified disease-causing molecular genetic defects are continuously expanding. The diagnostic examination of patients requires a multi-disciplinary clinical and laboratory evaluation in which the biochemical examination of the mitochondrial functional state often plays a central role. In most cases, a muscle biopsy provides the best opportunity to examine mitochondrial function. In addition to activity measurements of individual oxidative phosphorylation enzymes, analysis of mitochondrial respiration, substrate oxidation, and ATP production rates is performed to obtain a detailed picture of the mitochondrial energy-generating system. On the basis of the compilation of clinical, biochemical, and other laboratory test results, candidate genes are selected for molecular genetic testing. In patients in whom an unknown genetic variant is identified, a compatible biochemical phenotype is often required to firmly establish the diagnosis. In addition to the current role of the biochemical analysis in the diagnostic examination of patients with a suspected mitochondria disorder, this report gives a future perspective on the biochemical diagnosis in view of both the expanding genotypes of mitochondrial disorders and the possibilities for high throughput molecular genetic diagnosis.
Literature
go back to reference Benit P, Chretien D, Kadhom N et al (2001) Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet 68:1344–1352PubMedCrossRef Benit P, Chretien D, Kadhom N et al (2001) Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet 68:1344–1352PubMedCrossRef
go back to reference Benit P, Goncalves S, Philippe DE, Briere JJ, Martin G, Rustin P (2006) Three spectrophotometric assays for the measurement of the five respiratory chain complexes in minuscule biological samples. Clin Chim Acta 374:81–86PubMedCrossRef Benit P, Goncalves S, Philippe DE, Briere JJ, Martin G, Rustin P (2006) Three spectrophotometric assays for the measurement of the five respiratory chain complexes in minuscule biological samples. Clin Chim Acta 374:81–86PubMedCrossRef
go back to reference Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR (2002) Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59:1406–1411PubMed Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR (2002) Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59:1406–1411PubMed
go back to reference Bonnefont JP, Chretien D, Rustin P et al (1992) Alpha-ketoglutarate dehydrogenase deficiency presenting as congenital lactic acidosis. J Pediatr 121:255–258PubMedCrossRef Bonnefont JP, Chretien D, Rustin P et al (1992) Alpha-ketoglutarate dehydrogenase deficiency presenting as congenital lactic acidosis. J Pediatr 121:255–258PubMedCrossRef
go back to reference Brivet M, Garcia-Cazorla A, Lyonnet S et al (2003) Impaired mitochondrial pyruvate importation in a patient and a fetus at risk. Mol Genet Metab 78:186–192PubMedCrossRef Brivet M, Garcia-Cazorla A, Lyonnet S et al (2003) Impaired mitochondrial pyruvate importation in a patient and a fetus at risk. Mol Genet Metab 78:186–192PubMedCrossRef
go back to reference Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303–1308PubMedCrossRef Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303–1308PubMedCrossRef
go back to reference Cameron JM, Levandovskiy V, MacKay N, Robinson BH (2004) Respiratory chain analysis of skin fibroblasts in mitochondrial disease. Mitochondrion 4:387–394PubMedCrossRef Cameron JM, Levandovskiy V, MacKay N, Robinson BH (2004) Respiratory chain analysis of skin fibroblasts in mitochondrial disease. Mitochondrion 4:387–394PubMedCrossRef
go back to reference Cameron JM, Maj M, Levandovskiy V et al (2009) Pyruvate dehydrogenase phosphatase 1 (PDP1) null mutation produces a lethal infantile phenotype. Hum Genet 125:319–326PubMedCrossRef Cameron JM, Maj M, Levandovskiy V et al (2009) Pyruvate dehydrogenase phosphatase 1 (PDP1) null mutation produces a lethal infantile phenotype. Hum Genet 125:319–326PubMedCrossRef
go back to reference Carrozzo R, Dionisi-Vici C, Steuerwald U et al (2007) SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 130:862–874PubMedCrossRef Carrozzo R, Dionisi-Vici C, Steuerwald U et al (2007) SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 130:862–874PubMedCrossRef
go back to reference Coenen MJ, Antonicka H, Ugalde C et al (2004) Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med 351:2080–2086PubMedCrossRef Coenen MJ, Antonicka H, Ugalde C et al (2004) Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med 351:2080–2086PubMedCrossRef
go back to reference de Vries MC, Rodenburg RJ, Morava E et al (2007) Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations. Eur J Pediatr 166:229–234PubMedCrossRef de Vries MC, Rodenburg RJ, Morava E et al (2007) Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations. Eur J Pediatr 166:229–234PubMedCrossRef
go back to reference de Vries MC, Rodenburg RJ, Morava E et al (2008) Normal biochemical analysis of the oxidative phosphorylation (OXPHOS) system in a child with POLG mutations: a cautionary note. J Inherit Metab Dis 31:547–547 de Vries MC, Rodenburg RJ, Morava E et al (2008) Normal biochemical analysis of the oxidative phosphorylation (OXPHOS) system in a child with POLG mutations: a cautionary note. J Inherit Metab Dis 31:547–547
go back to reference Duncan AJ, Heales SJ, Mills K, Eaton S, Land JM, Hargreaves IP (2005) Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with di-propoxy-coenzyme Q10 as an internal standard. Clin Chem 51:2380–2382PubMedCrossRef Duncan AJ, Heales SJ, Mills K, Eaton S, Land JM, Hargreaves IP (2005) Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with di-propoxy-coenzyme Q10 as an internal standard. Clin Chem 51:2380–2382PubMedCrossRef
go back to reference Edvardson S, Shaag A, Kolesnikova O et al (2007) Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 81:857–862PubMedCrossRef Edvardson S, Shaag A, Kolesnikova O et al (2007) Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 81:857–862PubMedCrossRef
go back to reference Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254–260PubMedCrossRef Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254–260PubMedCrossRef
go back to reference Finsterer J, Harbo HF, Baets J et al (2009) EFNS guidelines on the molecular diagnosis of mitochondrial disorders. Eur J Neurol 16:1255–1264PubMedCrossRef Finsterer J, Harbo HF, Baets J et al (2009) EFNS guidelines on the molecular diagnosis of mitochondrial disorders. Eur J Neurol 16:1255–1264PubMedCrossRef
go back to reference Garcia-Cazorla A, de Lonlay P, Rustin P et al (2006) Mitochondrial respiratory chain deficiencies expressing the enzymatic deficiency in the hepatic tissue: a study of 31 patients. J Pediatr 149:401–405PubMedCrossRef Garcia-Cazorla A, de Lonlay P, Rustin P et al (2006) Mitochondrial respiratory chain deficiencies expressing the enzymatic deficiency in the hepatic tissue: a study of 31 patients. J Pediatr 149:401–405PubMedCrossRef
go back to reference Gellerich FN, Mayr JA, Reuter S, Sperl W, Zierz S (2004) The problem of interlab variation in methods for mitochondrial disease diagnosis: enzymatic measurement of respiratory chain complexes. Mitochondrion 4:427–439PubMedCrossRef Gellerich FN, Mayr JA, Reuter S, Sperl W, Zierz S (2004) The problem of interlab variation in methods for mitochondrial disease diagnosis: enzymatic measurement of respiratory chain complexes. Mitochondrion 4:427–439PubMedCrossRef
go back to reference Haas R, Stumpf DA, Parks JK, Eguren L (1981) Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology 31:1473–1476PubMed Haas R, Stumpf DA, Parks JK, Eguren L (1981) Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology 31:1473–1476PubMed
go back to reference Haas RH, Parikh S, Falk MJ et al (2007) Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 120:1326–1333PubMedCrossRef Haas RH, Parikh S, Falk MJ et al (2007) Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 120:1326–1333PubMedCrossRef
go back to reference Haas RH, Parikh S, Falk MJ et al (2008) The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 94:16–37PubMedCrossRef Haas RH, Parikh S, Falk MJ et al (2008) The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 94:16–37PubMedCrossRef
go back to reference Hoefs SJ, Dieteren CE, Distelmaier F et al (2008) NDUFA2 complex I mutation leads to Leigh disease. Am J Hum Genet 82:1306–1315PubMedCrossRef Hoefs SJ, Dieteren CE, Distelmaier F et al (2008) NDUFA2 complex I mutation leads to Leigh disease. Am J Hum Genet 82:1306–1315PubMedCrossRef
go back to reference Hoffmann M, Bellance N, Rossignol R et al (2009) C. elegans ATAD-3 is essential for mitochondrial activity and development. PLoS ONE 4:e7644–e7644PubMedCrossRef Hoffmann M, Bellance N, Rossignol R et al (2009) C. elegans ATAD-3 is essential for mitochondrial activity and development. PLoS ONE 4:e7644–e7644PubMedCrossRef
go back to reference Honzik T, Wenchich L, Bohm M et al (2008) Activities of respiratory chain complexes and pyruvate dehydrogenase in isolated muscle mitochondria in premature neonates. Early Hum Dev 84:269–276PubMedCrossRef Honzik T, Wenchich L, Bohm M et al (2008) Activities of respiratory chain complexes and pyruvate dehydrogenase in isolated muscle mitochondria in premature neonates. Early Hum Dev 84:269–276PubMedCrossRef
go back to reference Horvath R, Hudson G, Ferrari G et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129:1674–1684PubMedCrossRef Horvath R, Hudson G, Ferrari G et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129:1674–1684PubMedCrossRef
go back to reference Huynen MA, de HM, Szklarczyk R (2009) Mitochondrial proteome evolution and genetic disease. Biochim Biophys Acta 1792:1122–1129PubMed Huynen MA, de HM, Szklarczyk R (2009) Mitochondrial proteome evolution and genetic disease. Biochim Biophys Acta 1792:1122–1129PubMed
go back to reference Janssen AJ, Smeitink JA, van den Heuvel LP (2003) Some practical aspects of providing a diagnostic service for respiratory chain defects. Ann Clin Biochem 40:3–8PubMedCrossRef Janssen AJ, Smeitink JA, van den Heuvel LP (2003) Some practical aspects of providing a diagnostic service for respiratory chain defects. Ann Clin Biochem 40:3–8PubMedCrossRef
go back to reference Janssen AJ, Trijbels FJ, Sengers RC et al (2006) Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology. Clin Chem 52:860–871PubMedCrossRef Janssen AJ, Trijbels FJ, Sengers RC et al (2006) Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology. Clin Chem 52:860–871PubMedCrossRef
go back to reference Janssen AJ, Trijbels FJ, Sengers RC et al (2007) Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin Chem 53:729–734PubMedCrossRef Janssen AJ, Trijbels FJ, Sengers RC et al (2007) Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin Chem 53:729–734PubMedCrossRef
go back to reference Janssen AJ, Schuelke M, Smeitink JA et al (2008) Muscle 3243A−>G mutation load and capacity of the mitochondrial energy-generating system. Ann Neurol 63:473–481PubMedCrossRef Janssen AJ, Schuelke M, Smeitink JA et al (2008) Muscle 3243A−>G mutation load and capacity of the mitochondrial energy-generating system. Ann Neurol 63:473–481PubMedCrossRef
go back to reference Jonckheere AI, Hogeveen M, Nijtmans LG et al (2008) A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy. J Med Genet 45:129–133PubMedCrossRef Jonckheere AI, Hogeveen M, Nijtmans LG et al (2008) A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy. J Med Genet 45:129–133PubMedCrossRef
go back to reference Jonckheere AI, Huigsloot M, Janssen AJ, Kappen AJ, Smeitink JA, Rodenburg RJ (2010) High-Throughput Assay to Measure Oxygen Consumption in Digitonin-Permeabilized Cells of Patients with Mitochondrial Disorders. Clin Chem 56:424–431 Jonckheere AI, Huigsloot M, Janssen AJ, Kappen AJ, Smeitink JA, Rodenburg RJ (2010) High-Throughput Assay to Measure Oxygen Consumption in Digitonin-Permeabilized Cells of Patients with Mitochondrial Disorders. Clin Chem 56:424–431
go back to reference Kavanaugh-Black A, Connolly DM, Chugani SA, Chakrabarty AM (1994) Characterization of nucleoside-diphosphate kinase from Pseudomonas aeruginosa: complex formation with succinyl-CoA synthetase. Proc Natl Acad Sci USA 91:5883–5887PubMedCrossRef Kavanaugh-Black A, Connolly DM, Chugani SA, Chakrabarty AM (1994) Characterization of nucleoside-diphosphate kinase from Pseudomonas aeruginosa: complex formation with succinyl-CoA synthetase. Proc Natl Acad Sci USA 91:5883–5887PubMedCrossRef
go back to reference King MP, Attardi G (1989) Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246:500–503PubMedCrossRef King MP, Attardi G (1989) Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246:500–503PubMedCrossRef
go back to reference Kirby DM, Thorburn DR, Turnbull DM, Taylor RW (2007) Biochemical assays of respiratory chain complex activity. Methods Cell Biol 80:93–119PubMedCrossRef Kirby DM, Thorburn DR, Turnbull DM, Taylor RW (2007) Biochemical assays of respiratory chain complex activity. Methods Cell Biol 80:93–119PubMedCrossRef
go back to reference Kirkman MA, Yu-Wai-Man P, Chinnery PF (2008) The clinical spectrum of mitochondrial genetic disorders. Clin Med 8:601–606PubMed Kirkman MA, Yu-Wai-Man P, Chinnery PF (2008) The clinical spectrum of mitochondrial genetic disorders. Clin Med 8:601–606PubMed
go back to reference Koopman WJ, Verkaart S, van Emst-de Vries SE et al (2008) Mitigation of NADH: ubiquinone oxidoreductase deficiency by chronic Trolox treatment. Biochim Biophys Acta 1777:853–859PubMedCrossRef Koopman WJ, Verkaart S, van Emst-de Vries SE et al (2008) Mitigation of NADH: ubiquinone oxidoreductase deficiency by chronic Trolox treatment. Biochim Biophys Acta 1777:853–859PubMedCrossRef
go back to reference Loeffen J, Smeitink J, Triepels R et al (1998) The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 63:1598–1608PubMedCrossRef Loeffen J, Smeitink J, Triepels R et al (1998) The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 63:1598–1608PubMedCrossRef
go back to reference Loeffen JL, Smeitink JA, Trijbels JM et al (2000) Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 15:123–134PubMedCrossRef Loeffen JL, Smeitink JA, Trijbels JM et al (2000) Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 15:123–134PubMedCrossRef
go back to reference Lopez LC, Schuelke M, Quinzii CM et al (2006) Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 79:1125–1129PubMedCrossRef Lopez LC, Schuelke M, Quinzii CM et al (2006) Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 79:1125–1129PubMedCrossRef
go back to reference Mandel H, Szargel R, Labay V et al (2001) The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29:337–341PubMedCrossRef Mandel H, Szargel R, Labay V et al (2001) The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29:337–341PubMedCrossRef
go back to reference Mayr JA, Merkel O, Kohlwein SD et al (2007) Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylation. Am J Hum Genet 80:478–484PubMedCrossRef Mayr JA, Merkel O, Kohlwein SD et al (2007) Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylation. Am J Hum Genet 80:478–484PubMedCrossRef
go back to reference Medja F, Allouche S, Frachon P et al (2009) Development and implementation of standardized respiratory chain spectrophotometric assays for clinical diagnosis. Mitochondrion 9:331–339PubMedCrossRef Medja F, Allouche S, Frachon P et al (2009) Development and implementation of standardized respiratory chain spectrophotometric assays for clinical diagnosis. Mitochondrion 9:331–339PubMedCrossRef
go back to reference Meisinger C, Sickmann A, Pfanner N (2008) The mitochondrial proteome: from inventory to function. Cell 134:22–24PubMedCrossRef Meisinger C, Sickmann A, Pfanner N (2008) The mitochondrial proteome: from inventory to function. Cell 134:22–24PubMedCrossRef
go back to reference Miller C, Saada A, Shaul N et al (2004) Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol 56:734–738PubMedCrossRef Miller C, Saada A, Shaul N et al (2004) Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol 56:734–738PubMedCrossRef
go back to reference Molinari F, Raas-Rothschild A, Rio M et al (2005) Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet 76:334–339PubMedCrossRef Molinari F, Raas-Rothschild A, Rio M et al (2005) Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet 76:334–339PubMedCrossRef
go back to reference Morava E, van den Heuvel L, Hol F et al (2006) Mitochondrial disease criteria: diagnostic applications in children. Neurology 67:1823–1826PubMedCrossRef Morava E, van den Heuvel L, Hol F et al (2006) Mitochondrial disease criteria: diagnostic applications in children. Neurology 67:1823–1826PubMedCrossRef
go back to reference Morava E, Steuerwald U, Carrozzo R et al (2009) Dystonia and deafness due to SUCLA2 defect; clinical course and biochemical markers in 16 children. Mitochondrion 9:438–442PubMedCrossRef Morava E, Steuerwald U, Carrozzo R et al (2009) Dystonia and deafness due to SUCLA2 defect; clinical course and biochemical markers in 16 children. Mitochondrion 9:438–442PubMedCrossRef
go back to reference Niers LE, Smeitink JA, Trijbels JM, Sengers RC, Janssen AJ, van den Heuvel LP (2001) Prenatal diagnosis of NADH:ubiquinone oxidoreductase deficiency. Prenat Diagn 21:871–880PubMedCrossRef Niers LE, Smeitink JA, Trijbels JM, Sengers RC, Janssen AJ, van den Heuvel LP (2001) Prenatal diagnosis of NADH:ubiquinone oxidoreductase deficiency. Prenat Diagn 21:871–880PubMedCrossRef
go back to reference Niers L, van den Heuvel L, Trijbels F, Sengers R, Smeitink J (2003) Prerequisites and strategies for prenatal diagnosis of respiratory chain deficiency in chorionic villi. J Inherit Metab Dis 26:647–658PubMedCrossRef Niers L, van den Heuvel L, Trijbels F, Sengers R, Smeitink J (2003) Prerequisites and strategies for prenatal diagnosis of respiratory chain deficiency in chorionic villi. J Inherit Metab Dis 26:647–658PubMedCrossRef
go back to reference Ostergaard E, Christensen E, Kristensen E et al (2007) Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet 81:383–387PubMedCrossRef Ostergaard E, Christensen E, Kristensen E et al (2007) Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet 81:383–387PubMedCrossRef
go back to reference Ostergaard E, Schwartz M, Batbayli M et al (2010) A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria. Eur J Pediatr 169:201–205PubMedCrossRef Ostergaard E, Schwartz M, Batbayli M et al (2010) A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria. Eur J Pediatr 169:201–205PubMedCrossRef
go back to reference Pagliarini DJ, Calvo SE, Chang B et al (2008) A mitochondrial protein compendium elucidates complex I disease biology. Cell 134:112–123PubMedCrossRef Pagliarini DJ, Calvo SE, Chang B et al (2008) A mitochondrial protein compendium elucidates complex I disease biology. Cell 134:112–123PubMedCrossRef
go back to reference Palmieri F (2008) Diseases caused by defects of mitochondrial carriers: a review. Biochim Biophys Acta 1777:564–578PubMedCrossRef Palmieri F (2008) Diseases caused by defects of mitochondrial carriers: a review. Biochim Biophys Acta 1777:564–578PubMedCrossRef
go back to reference Phillips D, Aponte AM, French SA, Chess DJ, Balaban RS (2009) Succinyl-CoA synthetase is a phosphate target for the activation of mitochondrial metabolism. Biochemistry 48:7140–7149PubMedCrossRef Phillips D, Aponte AM, French SA, Chess DJ, Balaban RS (2009) Succinyl-CoA synthetase is a phosphate target for the activation of mitochondrial metabolism. Biochemistry 48:7140–7149PubMedCrossRef
go back to reference Rahman S, Hargreaves I, Clayton P, Heales S (2001) Neonatal presentation of coenzyme Q10 deficiency. J Pediatr 139:456–458PubMedCrossRef Rahman S, Hargreaves I, Clayton P, Heales S (2001) Neonatal presentation of coenzyme Q10 deficiency. J Pediatr 139:456–458PubMedCrossRef
go back to reference Reisch AS, Elpeleg O (2007) Biochemical assays for mitochondrial activity: assays of TCA cycle enzymes and PDHc. Methods Cell Biol 80:199–222PubMedCrossRef Reisch AS, Elpeleg O (2007) Biochemical assays for mitochondrial activity: assays of TCA cycle enzymes and PDHc. Methods Cell Biol 80:199–222PubMedCrossRef
go back to reference Rustin P, Chretien D, Bourgeron T et al (1991) Assessment of the mitochondrial respiratory chain. Lancet 338:60–60PubMedCrossRef Rustin P, Chretien D, Bourgeron T et al (1991) Assessment of the mitochondrial respiratory chain. Lancet 338:60–60PubMedCrossRef
go back to reference Rustin P, Chretien D, Bourgeron T et al (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228:35–51PubMedCrossRef Rustin P, Chretien D, Bourgeron T et al (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228:35–51PubMedCrossRef
go back to reference Saada A, Shaag A, Arnon S et al (2007) Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation. J Med Genet 44:784–786PubMedCrossRef Saada A, Shaag A, Arnon S et al (2007) Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation. J Med Genet 44:784–786PubMedCrossRef
go back to reference Schaefer AM, McFarland R, Blakely EL et al (2008) Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63:35–39PubMedCrossRef Schaefer AM, McFarland R, Blakely EL et al (2008) Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63:35–39PubMedCrossRef
go back to reference Schagger H, von Jagow G (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199:223–231PubMedCrossRef Schagger H, von Jagow G (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199:223–231PubMedCrossRef
go back to reference Scheper GC, van der KT, van Andel RJ et al (2007) Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39:534–539 Scheper GC, van der KT, van Andel RJ et al (2007) Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39:534–539
go back to reference Schwab MA, Sauer SW, Okun JG et al (2006) Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J 398:107–112PubMedCrossRef Schwab MA, Sauer SW, Okun JG et al (2006) Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J 398:107–112PubMedCrossRef
go back to reference Smeitink JA, Elpeleg O, Antonicka H et al (2006) Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet 79:869–877PubMedCrossRef Smeitink JA, Elpeleg O, Antonicka H et al (2006) Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet 79:869–877PubMedCrossRef
go back to reference Sperl W, Sengers RC, Trijbels JM et al (1992) Enzyme activities of the mitochondrial energy generating system in skeletal muscle tissue of preterm and fullterm neonates. Ann Clin Biochem 29:638–645PubMed Sperl W, Sengers RC, Trijbels JM et al (1992) Enzyme activities of the mitochondrial energy generating system in skeletal muscle tissue of preterm and fullterm neonates. Ann Clin Biochem 29:638–645PubMed
go back to reference Spinazzola A, Viscomi C, Fernandez-Vizarra E et al (2006) MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 38:570–575PubMedCrossRef Spinazzola A, Viscomi C, Fernandez-Vizarra E et al (2006) MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 38:570–575PubMedCrossRef
go back to reference Taylor RW, Birch-Machin MA, Bartlett K, Turnbull DM (1993) Succinate-cytochrome c reductase: assessment of its value in the investigation of defects of the respiratory chain. Biochim Biophys Acta 1181:261–265PubMed Taylor RW, Birch-Machin MA, Bartlett K, Turnbull DM (1993) Succinate-cytochrome c reductase: assessment of its value in the investigation of defects of the respiratory chain. Biochim Biophys Acta 1181:261–265PubMed
go back to reference Taylor RW, Birch-Machin MA, Schaefer J et al (1996) Deficiency of complex II of the mitochondrial respiratory chain in late-onset optic atrophy and ataxia. Ann Neurol 39:224–232PubMedCrossRef Taylor RW, Birch-Machin MA, Schaefer J et al (1996) Deficiency of complex II of the mitochondrial respiratory chain in late-onset optic atrophy and ataxia. Ann Neurol 39:224–232PubMedCrossRef
go back to reference Taylor RW, Giordano C, Davidson MM et al (2003) A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J Am Coll Cardiol 41:1786–1796PubMedCrossRef Taylor RW, Giordano C, Davidson MM et al (2003) A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J Am Coll Cardiol 41:1786–1796PubMedCrossRef
go back to reference Thorburn DR, Smeitink J (2001) Diagnosis of mitochondrial disorders: clinical and biochemical approach. J Inherit Metab Dis 24:312–316PubMedCrossRef Thorburn DR, Smeitink J (2001) Diagnosis of mitochondrial disorders: clinical and biochemical approach. J Inherit Metab Dis 24:312–316PubMedCrossRef
go back to reference Tiranti V, Viscomi C, Hildebrandt T et al (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15:200–205PubMedCrossRef Tiranti V, Viscomi C, Hildebrandt T et al (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15:200–205PubMedCrossRef
go back to reference Trijbels JM, Sengers RC, Ruitenbeek W, Fischer JC, Bakkeren JA, Janssen AJ (1988) Disorders of the mitochondrial respiratory chain: clinical manifestations and diagnostic approach. Eur J Pediatr 148:92–97PubMedCrossRef Trijbels JM, Sengers RC, Ruitenbeek W, Fischer JC, Bakkeren JA, Janssen AJ (1988) Disorders of the mitochondrial respiratory chain: clinical manifestations and diagnostic approach. Eur J Pediatr 148:92–97PubMedCrossRef
go back to reference Van Coster R, Smet J, George E et al (2001) Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects. Pediatr Res 50:658–665PubMedCrossRef Van Coster R, Smet J, George E et al (2001) Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects. Pediatr Res 50:658–665PubMedCrossRef
go back to reference van den Heuvel L, Ruitenbeek W, Smeets R et al (1998) Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 62:262–268PubMedCrossRef van den Heuvel L, Ruitenbeek W, Smeets R et al (1998) Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 62:262–268PubMedCrossRef
go back to reference van den Heuvel LP, Smeitink JA, Rodenburg RJ (2004) Biochemical examination of fibroblasts in the diagnosis and research of oxidative phosphorylation (OXPHOS) defects. Mitochondrion 4:395–401PubMedCrossRef van den Heuvel LP, Smeitink JA, Rodenburg RJ (2004) Biochemical examination of fibroblasts in the diagnosis and research of oxidative phosphorylation (OXPHOS) defects. Mitochondrion 4:395–401PubMedCrossRef
go back to reference van Eijsden RG, Gerards M, Eijssen LM et al (2006) Chip-based mtDNA mutation screening enables fast and reliable genetic diagnosis of OXPHOS patients. Genet Med 8:620–627PubMedCrossRef van Eijsden RG, Gerards M, Eijssen LM et al (2006) Chip-based mtDNA mutation screening enables fast and reliable genetic diagnosis of OXPHOS patients. Genet Med 8:620–627PubMedCrossRef
go back to reference Van Goethem G, Luoma P, Rantamaki M et al (2004) POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 63:1251–1257PubMed Van Goethem G, Luoma P, Rantamaki M et al (2004) POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 63:1251–1257PubMed
go back to reference Vasta V, Ng SB, Turner EH, Shendure J, Hahn SH (2009) Next generation sequence analysis for mitochondrial disorders. Genome Med 1:100–100PubMedCrossRef Vasta V, Ng SB, Turner EH, Shendure J, Hahn SH (2009) Next generation sequence analysis for mitochondrial disorders. Genome Med 1:100–100PubMedCrossRef
go back to reference Vesela K, Hansikova H, Tesarova M et al (2004) Clinical, biochemical and molecular analyses of six patients with isolated cytochrome c oxidase deficiency due to mutations in the SCO2 gene. Acta Paediatr 93:1312–1317PubMedCrossRef Vesela K, Hansikova H, Tesarova M et al (2004) Clinical, biochemical and molecular analyses of six patients with isolated cytochrome c oxidase deficiency due to mutations in the SCO2 gene. Acta Paediatr 93:1312–1317PubMedCrossRef
go back to reference Walker UA, Collins S, Byrne E (1996) Respiratory chain encephalomyopathies: a diagnostic classification. Eur Neurol 36:260–267PubMedCrossRef Walker UA, Collins S, Byrne E (1996) Respiratory chain encephalomyopathies: a diagnostic classification. Eur Neurol 36:260–267PubMedCrossRef
go back to reference Wanders RJ, Ruiter JP, Wijburg FA (1993) Studies on mitochondrial oxidative phosphorylation in permeabilized human skin fibroblasts: application to mitochondrial encephalomyopathies. Biochim Biophys Acta 1181:219–222PubMed Wanders RJ, Ruiter JP, Wijburg FA (1993) Studies on mitochondrial oxidative phosphorylation in permeabilized human skin fibroblasts: application to mitochondrial encephalomyopathies. Biochim Biophys Acta 1181:219–222PubMed
go back to reference Wibom R, Lasorsa FM, Tohonen V et al (2009) AGC1 deficiency associated with global cerebral hypomyelination. N Engl J Med 361:489–495PubMedCrossRef Wibom R, Lasorsa FM, Tohonen V et al (2009) AGC1 deficiency associated with global cerebral hypomyelination. N Engl J Med 361:489–495PubMedCrossRef
go back to reference Will Y, Hynes J, Ogurtsov VI, Papkovsky DB (2006) Analysis of mitochondrial function using phosphorescent oxygen-sensitive probes. Nat Protoc 1:2563–2572PubMedCrossRef Will Y, Hynes J, Ogurtsov VI, Papkovsky DB (2006) Analysis of mitochondrial function using phosphorescent oxygen-sensitive probes. Nat Protoc 1:2563–2572PubMedCrossRef
go back to reference Willis JH, Capaldi RA, Huigsloot M, Rodenburg RJ, Smeitink J, Marusich MF (2009) Isolated deficiencies of OXPHOS complexes I and IV are identified accurately and quickly by simple enzyme activity immunocapture assays. Biochim Biophys Acta 1787:533–538PubMedCrossRef Willis JH, Capaldi RA, Huigsloot M, Rodenburg RJ, Smeitink J, Marusich MF (2009) Isolated deficiencies of OXPHOS complexes I and IV are identified accurately and quickly by simple enzyme activity immunocapture assays. Biochim Biophys Acta 1787:533–538PubMedCrossRef
go back to reference Wittig I, Carrozzo R, Santorelli FM, Schagger H (2007) Functional assays in high-resolution clear native gels to quantify mitochondrial complexes in human biopsies and cell lines. Electrophoresis 28:3811–3820PubMedCrossRef Wittig I, Carrozzo R, Santorelli FM, Schagger H (2007) Functional assays in high-resolution clear native gels to quantify mitochondrial complexes in human biopsies and cell lines. Electrophoresis 28:3811–3820PubMedCrossRef
go back to reference Wolf NI, Smeitink JA (2002) Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 59:1402–1405PubMed Wolf NI, Smeitink JA (2002) Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 59:1402–1405PubMed
go back to reference Wortmann S, Rodenburg RJ, Huizing M et al (2006) Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation. Mol Genet Metab 88:47–52PubMedCrossRef Wortmann S, Rodenburg RJ, Huizing M et al (2006) Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation. Mol Genet Metab 88:47–52PubMedCrossRef
go back to reference Wortmann SB, Rodenburg RJ, Jonckheere A et al (2009) Biochemical and genetic analysis of 3-methylglutaconic aciduria type IV: a diagnostic strategy. Brain 132:136–146PubMedCrossRef Wortmann SB, Rodenburg RJ, Jonckheere A et al (2009) Biochemical and genetic analysis of 3-methylglutaconic aciduria type IV: a diagnostic strategy. Brain 132:136–146PubMedCrossRef
go back to reference Zerbetto E, Vergani L, Dabbeni-Sala F (1997) Quantification of muscle mitochondrial oxidative phosphorylation enzymes via histochemical staining of blue native polyacrylamide gels. Electrophoresis 18:2059–2064PubMedCrossRef Zerbetto E, Vergani L, Dabbeni-Sala F (1997) Quantification of muscle mitochondrial oxidative phosphorylation enzymes via histochemical staining of blue native polyacrylamide gels. Electrophoresis 18:2059–2064PubMedCrossRef
go back to reference Zinn AB, Kerr DS, Hoppel CL (1986) Fumarase deficiency: a new cause of mitochondrial encephalomyopathy. N Engl J Med 315:469–475PubMedCrossRef Zinn AB, Kerr DS, Hoppel CL (1986) Fumarase deficiency: a new cause of mitochondrial encephalomyopathy. N Engl J Med 315:469–475PubMedCrossRef
Metadata
Title
Biochemical diagnosis of mitochondrial disorders
Author
Richard J. T. Rodenburg
Publication date
01-04-2011
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 2/2011
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9081-y

Other articles of this Issue 2/2011

Journal of Inherited Metabolic Disease 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.